Glaukos (GKOS) Profit After Tax (2014 - 2026)
Glaukos' (GKOS) quarterly Profit After Tax came in at -$18.4 million in Q2 2026, up 6.51% year-over-year from -$17.3 million in Q2 2025, and up 7.11% quarter-over-quarter from -$19.8 million in Q1 2026.
Analysis
Glaukos (GKOS) Profit After Tax (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Profit After Tax for 13 consecutive years, with -$18.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Profit After Tax rose 6.51% year-over-year to -$18.4 million in Q2 2026; TTM through Jun 2026 was -$188.1 million, a 102.67% decrease from a year earlier, with the FY2025 full-year figure at -$187.7 million, down 28.23% from the prior year.
- Profit After Tax was -$18.4 million for Q2 2026 at Glaukos, up from -$19.8 million in the prior quarter.
- Over five years, Profit After Tax peaked at $5.4 million in Q1 2022 and troughed at -$133.7 million in Q4 2025.
- A 5-year average of -$33.7 million and a median of -$31.0 million in 2022 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax surged 132.65% in 2022 and tumbled 743.97% in 2023, its largest moves.
- Over 5 years, Profit After Tax stood at -$31.5 million in 2022, then slipped by 16.91% to -$36.8 million in 2023, then grew by 8.7% to -$33.6 million in 2024, then tumbled by 298.05% to -$133.7 million in 2025, then surged by 86.25% to -$18.4 million in 2026.
- The last three Profit After Tax figures came in at -$18.4 million (Q2 2026), -$19.8 million (Q1 2026), and -$133.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.57 Bn | 178.97 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 104.60 Bn | 101.12 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 66.50 Bn | 65.97 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | 241.90 Mn |
| 7 | Alcon | 33.97 Bn | 32.51 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.23 Bn | 30.29 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Glaukos | 10.68 Bn | 10.57 Bn | 151.59 Mn | -18.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -18.38 Mn |
| Mar 31, 2026 | -19.78 Mn |
| Dec 31, 2025 | -133.67 Mn |
| Sep 30, 2025 | -16.23 Mn |
| Jun 30, 2025 | -19.66 Mn |
| Mar 31, 2025 | -18.15 Mn |
| Dec 31, 2024 | -33.58 Mn |
| Sep 30, 2024 | -21.41 Mn |
| Jun 30, 2024 | -50.55 Mn |
| Mar 31, 2024 | -40.84 Mn |
| Dec 31, 2023 | -36.78 Mn |
| Sep 30, 2023 | -30.44 Mn |
| Jun 30, 2023 | -32.81 Mn |
| Mar 31, 2023 | -34.63 Mn |
| Dec 31, 2022 | -31.46 Mn |
| Sep 30, 2022 | -27.58 Mn |
| Jun 30, 2022 | -45.54 Mn |
| Mar 31, 2022 | 5.38 Mn |
| Dec 31, 2021 | -21.87 Mn |
| Sep 30, 2021 | 6.23 Mn |